Transaction #8604 · Form 4 · 0001980648-25-000004
BeOne Medicines Ltd. · Exercise / conversion · American Depositary Shares
BeOne Medicines Ltd. · Transacted November 12, 2025 · Filed November 14, 2025
What does this filing report?
An SEC Form 4 filing for BeOne Medicines Ltd. records an exercise / conversion involving American Depositary Shares on November 12, 2025. The reported quantity was 296. The filing date is November 14, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- BeOne Medicines Ltd.
- Company CIK
- 0001651308
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 296
- Reported price
- 159.03
- Reference value
- 47,072.88
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 996
- Ownership description
- Not reported
- SEC acceptance time
- Nov 14, 2025, 5:28 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Lee Chan Henry ↗
SVP, General Counsel
CIK 0001980648
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- Each American Depositary Share represents 13 Ordinary Shares.
- F2
- The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.
- F3
- The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.
- F4
- These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- F5
- These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- F6
- These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.